Spring 2026 funding cycle: Applications available until Monday, March 2nd, 2pm PT.
- Call opens: Wednesday, January 28, 2026
- Deadline: Monday, March 2, 2026 (2:00 pm PST)
- Funding results: Available before end of June 2026
Amount available: $50,000 in direct costs for 1 year
Apply through the UCSF Resource Allocation Program (RAP) portal
The CFAR Mentored Scientist Award (our primary award program) is a mentoring and training grant targeted toward early stage (either at a senior stage of clinical or postdoctoral training or junior faculty) investigators at UCSF or affiliated partner institutes in the conduct of an HIV research project. These awards are designed to acquire preliminary data and research skills to prepare investigators for a future grant effort. Applicants for this award must indicate a faculty research mentor(s) who will commit to guiding the applicant throughout the duration of the proposed project.
Designation of Mentor
All Mentored award applications from individuals at the Assistant Professor level or below require an HIV research mentor. Mentors can, but are not required to, have supervisory authority over the applicant. CFAR requires your research mentor’s support to advise and guide the research portion of your application before submitting it to RAP.
Of high interest to CFAR are investigations ranging from basic pathogenesis to clinical outcomes in the research areas of HIV/aging and inflammation, latency, cure, vaccines, co-infections, HIV in women, implementation science, and research related to HIV-infected and HIV-impacted Bay Area populations. Projects must be within NIH’s HIV/AIDS research high or medium priority areas. Projects in closely related areas (e.g. TB, HCV, drug use, etc.) must be clearly linked to HIV in order to be eligible for CFAR funding.
The award amount is $50,000 in direct costs for one year.
CFAR requests that applicants review the NIAID HIV Language Guide as they prepare their proposals so that they can follow best practices on language for communicating respectfully about HIV and related topics, including the use of person-first, non-stigmatizing language. Please contact us if you have any questions about this request.
For more detailed information about this RFA, please see the RAP Portal.
To see examples of previously funded projects, see the list below.
Mentored Science Awardees
135 Awards
-
Identifying Reasons for Late-Diagnosis of HIV: An Academic-Community Partnership to Improve Health Outcomes
Identifying Reasons for Late-Diagnosis of HIV: An Academic-Community Partnership to Improve Health Outcomes
Abstract
In the United States, nearly a third of those diagnosed with HIV were diagnosed late, meaning that they were diagnosed with AIDS at the same time as or within one year of their HIV diagnosis. Late HIV diagnosis is associated with poor treatment outcomes and, in turn, less viral suppression, greater transmission of HIV to those who are not infected, and increased HIV-related morbidity and mortality. The United States’ goal of reducing HIV in part by increasing peoples’ awareness of their HIV status cannot be achieved without addressing late diagnosis.
-
Identifying Reasons for Late-Diagnosis of HIV: An Academic-Community Partnership to Improve Health Outcomes
Identifying Reasons for Late-Diagnosis of HIV: An Academic-Community Partnership to Improve Health Outcomes
Abstract
In the United States, nearly a third of those diagnosed with HIV were diagnosed late, meaning that they were diagnosed with AIDS at the same time as or within one year of their HIV diagnosis. Late HIV diagnosis is associated with poor treatment outcomes and, in turn, less viral suppression, greater transmission of HIV to those who are not infected, and increased HIV-related morbidity and mortality. The United States’ goal of reducing HIV in part by increasing peoples’ awareness of their HIV status cannot be achieved without addressing late diagnosis.
-
Postpartum Adherence to HIV treatment and Prevention of Mother to Child Transmission Strategies: The Implications of Transitions Among Women Living with HIV in Kisumu County, Kenya.
Postpartum Adherence to HIV treatment and Prevention of Mother to Child Transmission Strategies: The Implications of Transitions Among Women Living with HIV in Kisumu County, Kenya.
Abstract
Prevention of mother to child transmission of HIV is now possible through evidence-based strategies that reduce the risk of transmission to less than 2%. However, the effectiveness of these strategies depends on the mothers living with HIV adhering to HIV treatment and being retained in care. Difficulties in adhering to prevention strategies has resulted in mother to child transmission (MTCT) rates that remain unacceptably high. In Kenya, MTCT rates are still estimated at around 14% with over 6,000 newly infected children in 2016.
-
Postpartum Adherence to HIV treatment and Prevention of Mother to Child Transmission Strategies: The Implications of Transitions Among Women Living with HIV in Kisumu County, Kenya.
Postpartum Adherence to HIV treatment and Prevention of Mother to Child Transmission Strategies: The Implications of Transitions Among Women Living with HIV in Kisumu County, Kenya.
Abstract
Prevention of mother to child transmission of HIV is now possible through evidence-based strategies that reduce the risk of transmission to less than 2%. However, the effectiveness of these strategies depends on the mothers living with HIV adhering to HIV treatment and being retained in care. Difficulties in adhering to prevention strategies has resulted in mother to child transmission (MTCT) rates that remain unacceptably high. In Kenya, MTCT rates are still estimated at around 14% with over 6,000 newly infected children in 2016.
-
Structure-based Tat/TAR inhibitor screening for the development of novel treatments and a cure for HIV/AIDS
Structure-based Tat/TAR inhibitor screening for the development of novel treatments and a cure for HIV/AIDS
Abstract
38 million people are currently living with HIV/AIDS. Although the progress in developing antiretroviral therapies (ART) has been enormous, ART is too expensive or inaccessible for a large fraction of infected individuals, and requires lifelong adherence to a treatment regimen. An HIV cure would address many of these problems, but is still missing.
-
Structure-based Tat/TAR inhibitor screening for the development of novel treatments and a cure for HIV/AIDS
Structure-based Tat/TAR inhibitor screening for the development of novel treatments and a cure for HIV/AIDS
Abstract
38 million people are currently living with HIV/AIDS. Although the progress in developing antiretroviral therapies (ART) has been enormous, ART is too expensive or inaccessible for a large fraction of infected individuals, and requires lifelong adherence to a treatment regimen. An HIV cure would address many of these problems, but is still missing.
-
Improving clinical care for HIV-infected transplant patients by innovations in rejection diagnostics
Improving clinical care for HIV-infected transplant patients by innovations in rejection diagnostics
Abstract
HIV-infected patients undergoing kidney transplantation are a unique patient subset with significantly increased episodes of graft rejection compared to non-infected transplant recipients. Biomarker development for monitoring of transplant rejection is a critically unmet need, particularly in HIV-infected individuals. Epigenetic mechanisms, including changes in DNA 5-methylcytosine (5mC), contribute to AR and can be used for HIV-infected kidney transplant recipients (HIVKT). screening.
-
Improving clinical care for HIV-infected transplant patients by innovations in rejection diagnostics
Improving clinical care for HIV-infected transplant patients by innovations in rejection diagnostics
Abstract
HIV-infected patients undergoing kidney transplantation are a unique patient subset with significantly increased episodes of graft rejection compared to non-infected transplant recipients. Biomarker development for monitoring of transplant rejection is a critically unmet need, particularly in HIV-infected individuals. Epigenetic mechanisms, including changes in DNA 5-methylcytosine (5mC), contribute to AR and can be used for HIV-infected kidney transplant recipients (HIVKT). screening.
-
Untangling the Gordian knot of HIV, stress, and cognitive function via a mixed methods study of food insecurity
Untangling the Gordian knot of HIV, stress, and cognitive function via a mixed methods study of food insecurity
Abstract
Food insecurity (FI) impacts health via biological, psychological, behavioral, and social-structural pathways. As such, the study of FI in the etiology of poor health has helped illuminate synergistic and multidimensional pathways by which to intervene. For older women of color living with HIV, FI presents a multidimensional challenge and highlights a “Gordian knot” of interactions between aging and living with HIV. For example, HIV accelerates aging-related inflammation that impacts the central nervous system, leading to neurocognitive decline.
-
Untangling the Gordian knot of HIV, stress, and cognitive function via a mixed methods study of food insecurity
Untangling the Gordian knot of HIV, stress, and cognitive function via a mixed methods study of food insecurity
Abstract
Food insecurity (FI) impacts health via biological, psychological, behavioral, and social-structural pathways. As such, the study of FI in the etiology of poor health has helped illuminate synergistic and multidimensional pathways by which to intervene. For older women of color living with HIV, FI presents a multidimensional challenge and highlights a “Gordian knot” of interactions between aging and living with HIV. For example, HIV accelerates aging-related inflammation that impacts the central nervous system, leading to neurocognitive decline.